Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Sep 18th, 7:02 PM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | 26.84 - 29.20 |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
New Research Suggests Dietary Change Could Improve Glioblastoma Treatment Outcomes
Researchers at the University of Michigan have published a study which suggests that implementing a dietary adjustment could make glioblastoma, a deadly type of brain cancer, more susceptible to chemotherapy and radiation treatments targeting the tumors in the brain.
Via Investor Brand Network · September 18, 2025
Tesla (NASDAQ: TSLA) has once again captured the financial world's attention with a significant stock rally in September 2025, a dramatic turnaround that has seen its shares move into positive territory for the year. This surge, fueled by a reported $1 billion stock purchase by CEO Elon Musk and optimistic
Via MarketMinute · September 17, 2025
Tesla (NASDAQ: TSLA) finds itself at a pivotal juncture, navigating a complex product landscape marked by both exciting advancements and significant challenges. The electric vehicle giant has recently rolled out a refreshed version of its popular Model Y in Europe, aiming to invigorate sales and maintain its competitive edge. Simultaneously,
Via MarketMinute · September 17, 2025
Oncotelic Therapeutics Inc. (OTLC) Champions Targeted RNA Therapy for Underserved Cancers
In a landscape where cancer and underserved diseases continue to devastate millions, the demand for groundbreaking RNA-based, immunotherapeutic, and targeted treatments has never been more urgent. Oncotelic Therapeutics (OTCQB: OTLC ) is answering this call with pioneering RNA candidates and strategic programs aimed at some of the most lethal and overlooked cancers.
Via Investor Brand Network · September 17, 2025
Shopping for a car can feel stressful, but it doesn’t have to be. At CarHub North York Chrysler, the focus is on making the entire experience easy and straightforward. It is one of the best Chrysler, Jeep, Dodge, RAM and Fiat dealerships in Ontario. They make buying, selling, financing, and servicing your car simple, transparent, and even enjoyable.
Via GlobePRwire · September 17, 2025
The financial markets in 2025 have been a rollercoaster, culminating in a period of unprecedented euphoria. Both the S&P 500 and the Nasdaq Composite have surged to remarkable new all-time highs, largely driven by a pivotal shift in trade policy: the Trump administration's strategic pause in escalating tariff increases.
Via MarketMinute · September 16, 2025
Frankfurt, Germany – September 2025 – In a move largely anticipated by markets, the European Central Bank (ECB) opted in September 2025 to keep its key interest rates unchanged, maintaining a "steady hand" on monetary policy. This decision marks a significant divergence from the Federal Reserve (Fed) across the Atlantic, which is
Via MarketMinute · September 16, 2025
BioMedNewsBreaks — NextPlat Corp (NASDAQ: NXPL, NXPLW) Launches Florida Sunshine Brand of Premium Vitamins and Supplements in Global Markets
NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company, announced the official launch of its Florida Sunshine brand of premium vitamins and supplements across U.S., UK, and European markets, with expansion to China via Alibaba’s Tmall Global expected in Q4 2025. Supported by AI-powered digital advertising and dedicated e-commerce storefronts, the rollout targets rising global demand for preventive health and wellness products. The Made-in-USA liposomal formulations include vitamins C and D3, CoQ10, and Lutein, offering advanced absorption technology for immunity, heart health, and overall wellness. CEO David Phipps said the launch positions NextPlat to capture significant growth opportunities in the multibillion-dollar nutraceuticals market.
Via Investor Brand Network · September 16, 2025
New Smart Pen Shows 96% Efficacy in Detecting Parkinson’s Disease
UCLA researchers have developed a smart pen that can detect Parkinson’s during its early stages when the symptoms relied upon for the usual way to diagnose it haven’t shown up yet. Initial tests of this pen revealed an accuracy rate of 96.22%.
Via Investor Brand Network · September 16, 2025
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches FAQ Page to Enhance Transparency and Investor Engagement
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for the detection and treatment of breast cancer, has launched a new Frequently Asked Questions page on its corporate website at www.izocorp.com/faq . The resource provides accessible information on the company’s IzoView Breast CT Imaging System, development milestones, and competitive positioning, addressing topics such as breast density, imaging workflow, and comparisons with other modalities. Optimized for search and AI platforms, the FAQ page supports Izotropic’s investor relations, clinical outreach, and advocacy initiatives.
Via Investor Brand Network · September 16, 2025
Miami is a glamorous city that is also associated with energy and sophistication. It has been a haven of business executives, celebrities, and global travelers since its lively nightlife and its white sand beaches. To the people coming into Miami International Airport (MIA), the trip cannot just begin as you get into downtown. Rather, it […]
Via Worldnewswire · September 16, 2025
Northridge, CA () September 15, 2025 -- George’s Alignment & Brake Service is expanding its presence to better serve drivers in Northridge and surrounding neighborhoods.
Via Prodigy · September 15, 2025
April 2nd, 2025, will forever be etched in financial history as "Liberation Day," a moniker ironically assigned by the U.S. administration to the day sweeping new tariff policies were enacted. Instead, the global markets experienced a liberation of capital, as widespread panic selling triggered the largest worldwide decline since
Via MarketMinute · September 12, 2025
HeartBeam Inc. (NASDAQ: BEAT) Prepares Innovative ECG Technology for Commercial Launch
In its most recent quarterly update, HeartBeam (NASDAQ: BEAT) is reporting that the company is on the verge of revolutionizing cardiac diagnostics with its groundbreaking ECG technology. The company is actively preparing for FDA 510(k) clearance of its innovative 12-lead ECG synthesis software for arrhythmia assessment while executing comprehensive commercial readiness plans for a technology that could transform how heart health is monitored both in clinical and home settings ( https://ibn.fm/dz7rY ).
Via Investor Brand Network · September 12, 2025
Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness
Researchers at University of Pittsburg have found that patients who consume sucralose regularly have a lower likelihood of benefiting from immunotherapy and having longer survival times. Sucralose is an artificial sweetener that is commonly used in a variety of diet products, such as Splenda. This research is the first to connect the dietary choices that people make to groundbreaking cancer treatments.
Via Investor Brand Network · September 12, 2025
Tesla's (NASDAQ: TSLA) audacious move to open its proprietary Supercharger network and connector, now formally known as the North American Charging Standard (NACS), has sent ripples through the automotive industry, effectively reshaping the future of electric vehicle (EV) charging infrastructure. This strategic repositioning is not merely a technical adjustment; it's
Via MarketMinute · September 11, 2025
BioMedNewsBreaks — Kairos Pharma Ltd. (NYSE American: KAPA) to Host KOL Event on Phase 2 ENV105 Prostate Cancer Trial
Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing innovative cancer therapeutics, announced it will host a key opinion leader event on Sept. 18, 2025, at 5 p.m. ET to discuss interim efficacy results from its Phase 2 trial of lead candidate ENV105 in advanced prostate cancer. CEO Dr. John Yu said the event will highlight safety and efficacy findings from the ENV105 and apalutamide combination therapy, with expert perspectives underscoring the compound’s potential role in addressing cancer drug resistance.
Via Investor Brand Network · September 11, 2025
Kennedy’s MAHA Plan to Make Kids Healthier Receives Mixed Reactions
On Tuesday, the U.S. federal administration published a report aimed at improving the health of children in the country. The report calls for wide-ranging policy changes and executive actions to tackle the chronic disease burden rising in the country. HHS Secretary Kennedy Jr. announced this report. However, reactions to the contents of the report have been mixed .
Via Investor Brand Network · September 11, 2025
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in MarketScreener Editorial on Targeted AI Applications
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for the more accurate screening, diagnosis and treatment of breast cancers, announced its sponsored placement in a MarketScreener.com editorial titled From Healthcare to Automation: Investing In Next AI Wave . The article discusses the growing adoption of specialized AI applications across industries and features Izotropic’s IzoView technology as a rare early-stage medtech opportunity with the potential to establish a new standard of care in breast cancer imaging.
Via Investor Brand Network · September 11, 2025
Download Workshop Manuals, the premier online destination for professional automotive repair documentation since 2005, today announced a major expansion of its digital workshop manual library, adding comprehensive coverage for the latest 2024-2025 model year vehicles across all major automotive segments.
Via Get News · September 10, 2025
The MeatStick V Wireless Smart Meat Thermometer has been honored with the Red Dot Award: Product Design 2025 in the Kitchen Appliances category, one of the world’s most respected design competitions.
Via Get News · September 10, 2025
HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System
For decades, the traditional 12-lead electrocardiogram (“ECG”) has been the gold standard in cardiac diagnostics, including arrhythmia assessment, offering a comprehensive assessment of the heart’s electrical activity. However, traditional 12-lead ECG systems often come with limitations such as cumbersome setups and restricted accessibility. HeartBeam (NASDAQ: BEAT) is addressing these challenges by developing the HeartBeam System, the first cable-free, high-fidelity ECG system that captures the heart’s electrical signals from three distinct directions and synthesizes the signals into a 12-lead ECG, enabling comprehensive arrhythmia assessment outside clinical settings. This innovative approach aims to revolutionize cardiac care by providing patients with the ability to monitor their heart health conveniently and accurately.
Via Investor Brand Network · September 10, 2025
American households are bracing for a significant financial hit as a wave of tariff-induced inflation sweeps across critical consumer goods and services. From the family car to essential baby products, and even the cost of staying healthy, prices are already on an upward trajectory or are poised for substantial hikes.
Via MarketMinute · September 10, 2025
BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma Featured on IBN’s BioMedWire Podcast
Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology company developing targeted cancer therapies with its proprietary RADR(R) AI platform, is featured in the latest episode of IBN’s BioMedWire Podcast. President, CEO and Director Panna Sharma discusses the company’s mission to accelerate cancer drug development using AI, outlines progress across three ongoing clinical trials and shares his outlook on the future of precision neuro-oncology.
Via Investor Brand Network · September 10, 2025
Nutriband Inc. (NASDAQ: NTRB): When Market Confidence Validates Scientific Innovation
The pharmaceutical sector is defined by a critical balance between innovation and validation. Breakthroughs can take years of research, but they only achieve true market credibility when investors, partners, or acquirers signal confidence in commercial potential. For companies tackling complex problems like opioid abuse, that validation becomes especially important.
Via Investor Brand Network · September 10, 2025